$1.55+1.19 (+323.14%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD
Scinai Immunotherapeutics (SCNI) Institutional Ownership
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
Sources Ownership filingsQuarter ended How we compute thisNot investment advice
13F fund flowQuarter ended Sep 30, 2026*: more funds trimmed or exited than added or entered, mild distribution (2 new · 1 increased · 4 reduced · 6 closed). Flows at this scale move slowly; treat as context. These positions are 51 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
share base unverified · 13 filers, Sep 30, 2026
# 13F FUNDS
13
13F VALUE
$76,403.00
53,822 shares
Percent withheld: shares outstanding implied from the quote (market cap divided by price) falls outside the plausible range, so the share base this percentage divides by is unverified. The filer count, share total and dollar value are as filed and are unaffected.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | GERMAIN MARK | director | Acquired · Grant / award | 120,000,000 | — | ↗ |
| Jun 16, 2026 | Reichman Amir | Chief Executive Officer | Acquired · Grant / award | 400,000,000 | — | ↗ |
* Holdings as reported for Sep 30, 2026, 51 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How many 13F filers hold Scinai Immunotherapeutics?
Scinai Immunotherapeutics was held by 13 13F filers as of Sep 30, 2026.
Not investment advice.

